NOT KNOWN FACTUAL STATEMENTS ABOUT NORFLUAZEPAM

a In-vitro metabolites noticed in frequent between respective seven most plentiful metabolites in b C. elegans, c HLM and d HepG2 designs.The opportunity of deacylation in vivo plus the conversion into AL-LAD or MIPLA needs to be further investigated. In addition, there are fears about the long run distribution of sheet drug prod